Jodi Lindsay

Title: Jodi Lindsay - Innovator in MRSA Detection

Introduction

Jodi Lindsay is a prominent inventor based in London, GB. She has made significant contributions to the field of medical diagnostics, particularly in the detection of antibiotic-resistant bacteria. Her work focuses on developing innovative solutions to combat the growing threat of Methicillin-resistant Staphylococcus aureus (MRSA).

Latest Patents

Jodi Lindsay holds 1 patent related to a new diagnostic test for identifying MRSA CC398. This clone has recently emerged in pigs and other domestic animals worldwide, displaying high levels of antibiotic resistance. The diagnostic test utilizes a single one-step PCR method that can be performed easily within a few hours. It targets a specific gene (sau1hsdS1) located on the chromosome of the bacterial species, allowing for rapid identification of MRSA at the clone level. The test also detects the gene conferring methicillin resistance (mecA), enabling quick differentiation between methicillin-susceptible and methicillin-resistant variants. Preliminary validation of the test has shown 100% sensitivity and specificity, making it a valuable tool for surveillance and control of MRSA CC398 in humans, animals, and food products.

Career Highlights

Throughout her career, Jodi has worked with esteemed organizations such as Statens Serum Institut and the University of Copenhagen. Her expertise in microbiology and diagnostics has positioned her as a leader in her field.

Collaborations

Jodi has collaborated with notable colleagues, including Marc Stegger and Luca Guardabassi, to advance research in antibiotic resistance and improve diagnostic methods.

Conclusion

Jodi Lindsay's innovative work in MRSA detection exemplifies her commitment to addressing critical health challenges. Her contributions are vital in the ongoing fight against antibiotic resistance, ensuring better health outcomes for both humans and animals.